Stephen P. Carey
2016
In 2016, Stephen P. Carey earned a total compensation of $1.5M as Vice President, Finance and Chief Financial Officer at ANI Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $96,012 |
|---|---|
| Option Awards | $1,146,500 |
| Salary | $229,848 |
| Total | $1,472,360 |
Carey received $1.1M in option awards, accounting for 78% of the total pay in 2016.
Carey also received $96K in non-equity incentive plan and $229.8K in salary.
Rankings
In 2016, Stephen P. Carey's compensation ranked 6,341st out of 14,075 executives tracked by ExecPay. In other words, Carey earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,341 out of 14,075 | 55th |
Division Manufacturing | 2,330 out of 5,489 | 58th |
Major group Chemicals And Allied Products | 764 out of 1,895 | 60th |
Industry group Drugs | 580 out of 1,538 | 62nd |
Industry Pharmaceutical Preparations | 458 out of 1,176 | 61st |
Source: SEC filing on April 6, 2017.
Carey's colleagues
We found four more compensation records of executives who worked with Stephen P. Carey at ANI Pharmaceuticals in 2016.
2016
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
2016
Charlotte Arnold
ANI Pharmaceuticals
Chief Financial Officer
2016
Robert Schrepfer
ANI Pharmaceuticals
Senior Vice President, New Business Development and Specialty Sales
2016
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
News
ANI Pharmaceuticals CEO Nikhil Lalwani's 2021 pay jumps 76% to $6.5M
March 25, 2022
ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
April 29, 2021
ANI Pharmaceuticals CEO Arthur Przybyl's 2019 pay jumps 39% to $5.8M
April 23, 2020
ANI Pharmaceuticals CEO Arthur Przybyl's 2018 pay rises 17% to $4.2M
April 4, 2019